Properties |
Information |
PhytoCAT-ID |
PhytoCAT-1731 |
Phytochemical name or plant extracts |
Saikosaponin-d (SSd) |
PMID |
19819234 |
Literature evidence |
Co-incubation of MCF-7 cells with 1 microM of ER antagonist ICI-182780 abolished the inductive effects of SSd on estrogen response element (ERE)-luciferase activity, suggesting that the estrogenic effects of SSd were mediated through the estrogen receptors. |
IUPAC name |
(2R,3S,4S,5R,6S)-2-[(2R,3R,5R,6R)-3,5-dihydroxy-2-[[(1S,2R,4S,5R,8R,9R,10S,13S,14R,17S,18R)-2-hydroxy-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracos-15-en-10-yl]oxy]-6-methyloxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol |
Phytochemicals’ class or type of plant extracts |
Saponin |
Source of phytochemicals or plant Extracts |
Bupleurum falcatum |
|
Geographical availability |
Albania, Austria, Belgium, Bulgaria, Central European Rus, Corse, Czechoslovakia, East European Russia, France, Germany, Great Britain, Hungary, Italy, Krym, North Caucasus, Poland, Romania, South European Russi, Switzerland, Transcaucasus, Ukraine, Yugoslavia |
Plant parts |
NA |
Other cancers |
Breast cancer |
Target gene or protein |
NA |
Gene or Protein evidence |
NA |
Target pathways |
1) The present study revealed that SSD induced apoptosis through the activation of the p38 mitogen‑activated protein kinase (MAPK) signaling pathway in human breast cancer MDA-MB-231 cells. 2) The results showed that SSd could activate ERE-luciferase activity via the ERalpha-mediated pathway in a dose-dependent manner (10 nM to 10 microM), whereas, the activation of ERbeta-mediated ERE-luciferase activity by SSd only occurred at a high concentration (10 microM). |
IC50 |
NA |
Potency |
In conclusion, the results of the present study indicated that SSd may represent a potent reversal agent for P-gp-mediated MDR in breast cancer therapy. |
Cell line/ mice model |
MCF-7, HeLa, MDA-MB-231 |
Additional information |
Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells. |
PubChem ID |
129637783 |
Additional PMIDs |
32468000 19819234 28554760 |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:839147-1 |
Safety |
NA |